The recent release of the final FDA guidelines on over-the-counter (OTC) and prescriptive hearing aid categories is detailed and complex.   In this episode, Amyn Amlani is joined by David Akbari, Senior Medical Science, Clinical and Regulatory Affairs Liaison at Intricon Corporation, to help breakdown the new regulations. 

Dr. Akbari provides listeners with an overview of the guidelines and their potential effect on professional scope and business practice.  

Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:  https://www.linkedin.com/company/this-week-in-hearing/ https://twitter.com/WeekinHearing